Pinacidil I. Ahnfelt-Rønne Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 4 - 9
In Vitro Studies on the Mode of Action of Pinacidil A. H. WestonK. M. BrayJ. S. Southerton Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 10 - 28
Ion Channel Effects of Pinacidil in Vascular Muscle K. Hermsmeyer Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 29 - 32
Vasodilatation with Pinacidil Mode of Action in Rat Resistance Vessels L. M. VidebaekC. AalkjaerM. J. Mulvany Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 33 - 40
Effects of Pinacidil on Bladder Muscle K.-E. AnderssonP.-O. AnderssonC. Sjögren Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 41 - 49
Panel Discussion: Section 1 K.-E. Andersson Section 1: Basic Mechanisms and Mode of Action 23 October 2012 Pages: 53 - 54
Long Term Haemodynamic Effects of Pinacidil and Hydralazine in Arterial Hypertension J. E. CarlsenH. Aerenlund JensenJ. Trap-Jensen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 55 - 63
Comparative Trial of Pinacidil versus Prazosin in Mild to Moderate Arterial Hypertension B. SterndorffP. Johansen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 64 - 66
Comparative Effects of Pinacidil and Nifedipine in the Treatment of Arterial Hypertension H. J. Jürgensen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 67 - 69
Effects of Long Term Treatment with Pinacidil and Nifedipine on Left Ventricular Anatomy and Function in Patients with Mild to Moderate Systemic Hypertension F. Steensgaard-HansenJ. E. Carlsen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 70 - 76
Double-Blind Comparator Trials with Pinacidil, a Potassium Channel Opener J. T. CallaghanM. R. GoldbergR. Brunelle Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 77 - 82
Pinacidil with and without Hydrochlorothiazide M. R. GoldbergW. W. Offen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 83 - 92
Panel Discussion: Section 2 H. A. Jensen Section 2: Clinical Studies and Therapeutic Use 23 October 2012 Pages: 96 - 97